January 20, 2022 BetterLife Receives FDA Response On Its Pre-IND Application For Major Depressive Disorder (MDD) Treatment With BETR-001
September 29, 2021 BetterLife Obtains TD-0148A Receptor Binding Data for IND-Enabling Pharmacology Studies
April 29, 2021 BetterLife Files Patent for Invention of Novel Subcutaneous Implant to Prevent Drug Diversion of LSD and Other Psychedelic Drugs
March 29, 2021 BetterLife Added to Horizons Psychedelic Stock Index ETF Announces Closing of Non-Brokered Private Placement
